Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma

NCT01612286 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: endostatin

Sponsor

Zhejiang Cancer Hospital